In this episode of the HVC Podcast, we're diving deep into the world of GLP-1 agonists with two experts in the field, Dr. Bhatt and Dr. Goins. These groundbreaking medications—Ozempic, WeGovy, and the newly introduced Zepbound—are making waves in the treatment of type 2 diabetes and obesity. But how do they work, and what sets them apart from other treatments? Join us as we discuss the benefits and considerations of these medicines.